Postgraduate Program in Science and Health, Federal University of Piauí, Teresina, Piauí, Brazil.
Department of Biophysics and Physiology, Nucleus of Study in Physiology Applied to Performance and Health (NEFADS), Federal University of Piauí, Teresina, Piauí, Brazil.
Nutr Clin Pract. 2022 Oct;37(5):1105-1116. doi: 10.1002/ncp.10901. Epub 2022 Aug 6.
Phase angle, obtained by bioelectrical impedance, is an indicator of cellular integrity and has been proposed as a prognostic parameter in patients who are critically ill. This systematic review aimed to evaluate the association between phase angle and adverse clinical outcomes in hospitalized patients with coronavirus disease-2019 (COVID-19). An extensive literature search was performed in the MEDLINE/PubMed, Embase, and Web of Science databases, with interest in observational studies evaluating the association between phase angle and adverse clinical outcomes in individuals aged ≥18 years hospitalized with COVID-19. Studies were independently selected by two reviewers, according to eligibility criteria. Subsequently, data were extracted and presented in a qualitative synthesis. The evaluation of the quality of the studies was performed according to the Newcastle-Ottawa scale. The full methodology was published in PROSPERO (ID CRD42022306177). A total of 392 articles were identified, resulting in seven selected studies, of which six were prospective cohorts and one was retrospective. In the quality assessment, six studies obtained scores equal to or greater than seven, indicating a low risk of bias. A total of 750 participants composed the samples of the selected studies. Five studies reported an independent association between phase angle and adverse clinical outcomes during hospitalization for COVID-19, with emphasis on prolonged hospitalization and mechanical ventilation and higher mortality in patients with a lower phase angle. Thus, phase angle measurement can be useful in the early identification of risks in patients hospitalized with COVID-19, for the purpose of adequacy of clinical management.
相位角是通过生物电阻抗获得的,是细胞完整性的指标,已被提议作为危重病患者的预后参数。本系统评价旨在评估相位角与 2019 年冠状病毒病(COVID-19)住院患者不良临床结局之间的关系。在 MEDLINE/PubMed、Embase 和 Web of Science 数据库中进行了广泛的文献检索,对评估相位角与≥18 岁因 COVID-19 住院的个体不良临床结局之间关系的观察性研究感兴趣。根据纳入标准,由两名评审员独立选择研究。随后,提取数据并进行定性综合。根据纽卡斯尔-渥太华量表评估研究的质量。完整的方法学已在 PROSPERO(ID CRD42022306177)中发表。共确定了 392 篇文章,最终选择了 7 篇研究,其中 6 篇为前瞻性队列研究,1 篇为回顾性研究。在质量评估中,有 6 项研究的评分等于或高于 7 分,表明偏倚风险较低。所选研究的样本共包括 750 名参与者。有 5 项研究报告了相位角与 COVID-19 住院期间不良临床结局之间的独立相关性,重点是住院时间延长和机械通气以及相位角较低的患者死亡率更高。因此,相位角测量可用于早期识别 COVID-19 住院患者的风险,以达到临床管理的充分性。